Research further shows a significant association between patients with psoriasis and an increased incidence of obstructive ...

The FDA grants rare pediatric disease designation for serious or life-threatening diseases that affect fewer than 200,000 people in the United States when those people are primarily younger than 18 ...

Nager syndrome (NS) is an extremely rare disease that causes developmental problems and anomalies in facial bone structures and limbs. While the causative gene is known, its underlying mechanisms ...

Machine learning models may be a useful tool for psoriasis severity assessment in clinical settings, despite a need for further research.

“The heroes here tonight are not make-believe heroes from Marvel Comics, but real-life heroes who have made an impact on ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Japanese artist Chigusa Kamamasu recently performed at Triveni Kala Sangam. This enchanting event was part of the Japan Month celebrations, aimed at promoting cultural exchange and deepening ties ...

Scalp psoriasis occurs in approximately 80% of patients with plaque psoriasis, the most common form of the condition, and is associated with itching, flaking, pain and bleeding. Sotyktu is already ...

Govinda's Daughter Opens Up: First Media Interview Following Gunshot Injury Actor-turned-politician Govinda is currently recovering from a gunshot injury. His family, including wife Sunita, son ...

Psoriasis affects approximately 3% of the global population, irrespective of demographic factors such as sex, age, or ethnicity. There are two major forms of psoriasis: plaque psoriasis ...

Corticosteroids. Corticosteroids (see Table 1, Table 2, Table 3, Table 4, Table 5, Table 6) come in differing potencies and are organized into a class system, with class I representing the ...

Credit: Hriana via Shutterstock. Leo Pharma has submitted a New Drug Application (NDA) to China’s National Medical Products Administration for Enstilar, targeting the treatment of adult patients with ...